Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CB1 inverse agonists(Cannabinoid CB1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H20N2O3S2 |
InChIKeyOLJKYUURSJSMLD-UHFFFAOYSA-N |
CAS Registry2090325-46-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | FR | 08 Mar 2022 |